These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1. Evolving Evidence-Based Value Assessment of One-Time Therapies: Tisagenlecleucel as a Case Study. Laetsch T; Zhang J; Yang H; Xie Y; Zhang D; Garrison L Appl Health Econ Health Policy; 2024 Sep; 22(5):749-765. PubMed ID: 38683438 [TBL] [Abstract] [Full Text] [Related]
2. CSRP1 Promotes Colon Adenocarcinoma Growth and Serves as an Independent Risk Biomarker for Worse Prognosis. Yu S; Zhao H; Meng H; Shi S; Cao S; Bian T; Ruan C Genet Res (Camb); 2023; 2023():8586507. PubMed ID: 37113556 [TBL] [Abstract] [Full Text] [Related]
3. [Prognostic Value of the Expression of Myeloid leukemia Factor 1-Interacting Protein in Gastric Cancer and Its Regulatory Role in Tumor Progression]. Yang Z; Zhang H; Xu MY; Zhang XF; Wang YY; Ge ST; Geng ZJ; Song X; Li J; Hu JG; Zuo LG Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 54(1):114-121. PubMed ID: 36647653 [TBL] [Abstract] [Full Text] [Related]
4. The cost-effectiveness of therapeutic drug monitoring for the prescription drug-based treatment of chronic myeloid leukemia. Conti RM; Padula WV; Becker RV; Salamone S J Manag Care Spec Pharm; 2021 Aug; 27(8):1077-1085. PubMed ID: 34337991 [No Abstract] [Full Text] [Related]
5. Oncolytic viruses as a promising therapeutic strategy against the detrimental health impacts of air pollution: The case of glioblastoma multiforme. Kazemi Shariat Panahi H; Dehhaghi M; Lam SS; Peng W; Aghbashlo M; Tabatabaei M; Guillemin GJ Semin Cancer Biol; 2022 Nov; 86(Pt 3):1122-1142. PubMed ID: 34004331 [TBL] [Abstract] [Full Text] [Related]
6. Accuracy evaluation of the C. elegans cancer test (N-NOSE) using a new combined method. Inaba S; Shimozono N; Yabuki H; Enomoto M; Morishita M; Hirotsu T; di Luccio E Cancer Treat Res Commun; 2021; 27():100370. PubMed ID: 33901923 [TBL] [Abstract] [Full Text] [Related]
7. Identification of hub genes associated with adult acute myeloid leukemia progression through weighted gene co-expression network analysis. Zhu R; Lin W; Tang L; Hu Y Aging (Albany NY); 2021 Feb; 13(4):5686-5697. PubMed ID: 33592582 [TBL] [Abstract] [Full Text] [Related]
8. leukemia inhibitory factor is a novel biomarker to predict lymph node and distant metastasis in pancreatic cancer. Jiang W; Bai W; Li J; Liu J; Zhao K; Ren L Int J Cancer; 2021 Feb; 148(4):1006-1013. PubMed ID: 32914874 [TBL] [Abstract] [Full Text] [Related]
9. Influence of Internal and External Factors on the Production of Cytokines by Peripheral Blood Cells in Breast Cancer. Autenshlyus AI; Davletova KI; Mikhaylova ES; Proskura AV; Varaksin NA; Bogachuk AP; Sidorov SV; Lyakhovich VV; Lipkin VM Dokl Biochem Biophys; 2020 Jul; 493(1):178-180. PubMed ID: 32894459 [TBL] [Abstract] [Full Text] [Related]
10. Level of N6-Methyladenosine in Peripheral Blood RNA: A Novel Predictive Biomarker for Gastric Cancer. Ge L; Zhang N; Chen Z; Song J; Wu Y; Li Z; Chen F; Wu J; Li D; Li J; Wang C; Wang H; Wang J Clin Chem; 2020 Feb; 66(2):342-351. PubMed ID: 32040577 [TBL] [Abstract] [Full Text] [Related]
11. Chimeric antigen receptor T cells in solid tumors: a war against the tumor microenvironment. Zhao Z; Xiao X; Saw PE; Wu W; Huang H; Chen J; Nie Y Sci China Life Sci; 2020 Feb; 63(2):180-205. PubMed ID: 31883066 [TBL] [Abstract] [Full Text] [Related]
12. Blocking CD30 on T Cells by a Dual Specific CAR for CD30 and Colon Cancer Antigens Improves the CAR T Cell Response against CD30 Hombach AA; Rappl G; Abken H Mol Ther; 2019 Oct; 27(10):1825-1835. PubMed ID: 31331813 [TBL] [Abstract] [Full Text] [Related]
13. A distinguished cancer-screening package containing a DNA sensor and an aptasensor for early and certain detection of acute lymphoblastic leukemia. Mazloum-Ardakani M; Barazesh B; Moshtaghiun SM Clin Chim Acta; 2019 Oct; 497():41-47. PubMed ID: 31295447 [TBL] [Abstract] [Full Text] [Related]
14. Systematic review protocol: an assessment of the post-approval challenges of autologous CAR-T therapy delivery. Lam C; Meinert E; Halioua-Haubold CL; Carter A; Yang A; Brindley D; Cui Z BMJ Open; 2019 Jul; 9(7):e026172. PubMed ID: 31278092 [TBL] [Abstract] [Full Text] [Related]
15. Cost-effectiveness analysis of rasburicase over standard of care for the prevention and treatment of tumor lysis syndrome in children with hematologic malignancies in China. Hu S; Han Y; Zhang W; Zhang T; Yao X; Liu L J Med Econ; 2019 Aug; 22(8):742-750. PubMed ID: 30939962 [No Abstract] [Full Text] [Related]
16. Molecular Imaging of Radiolabeled Bispecific T-Cell Engager Waaijer SJH; Warnders FJ; Stienen S; Friedrich M; Sternjak A; Cheung HK; van Scheltinga AGTT; Schröder CP; de Vries EGE; Lub-de Hooge MN Clin Cancer Res; 2018 Oct; 24(20):4988-4996. PubMed ID: 29980531 [No Abstract] [Full Text] [Related]
17. Impact of microRNA-375 and its target gene SMAD-7 polymorphism on susceptibility of colorectal cancer. Shaker OG; Mohammed SR; Mohammed AM; Mahmoud Z J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28374902 [TBL] [Abstract] [Full Text] [Related]
18. Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers. Salmaninejad A; Zamani MR; Pourvahedi M; Golchehre Z; Hosseini Bereshneh A; Rezaei N Immunol Invest; 2016 Oct; 45(7):619-40. PubMed ID: 27603913 [TBL] [Abstract] [Full Text] [Related]
19. External radiation dose and cancer mortality among French nuclear workers: considering potential confounding by internal radiation exposure. Fournier L; Laurent O; Samson E; Caër-Lorho S; Laroche P; Le Guen B; Laurier D; Leuraud K Int Arch Occup Environ Health; 2016 Nov; 89(8):1183-1191. PubMed ID: 27383840 [TBL] [Abstract] [Full Text] [Related]
20. Harnessing T cells to fight cancer with BiTE® antibody constructs--past developments and future directions. Klinger M; Benjamin J; Kischel R; Stienen S; Zugmaier G Immunol Rev; 2016 Mar; 270(1):193-208. PubMed ID: 26864113 [TBL] [Abstract] [Full Text] [Related] [Next]